New hope for treatment of Alzheimer's disease

A genetic variant conveys significant protection

2014-07-15

(Press-News.org) Montreal, July 15 2014 - Judes Poirier, PhD, C.Q., from the Douglas Mental Health Institute and McGill University in Montréal (Canada) and his team have discovered that a relatively frequent genetic variant actually conveys significant protection against the common form of Alzheimer's disease and can delay the onset of the disease by as much as 4 years. This discovery opens new avenues for treatment against this devastating disease. Dr. Poirier announced his findings as the annual Alzheimer's Association International Conference was taking place in Copenhagen. This large-scale study identified naturally occurring genetic variants that provide protection against the common form of Alzheimer's disease, with the goal of identifying specific biological processes amenable to pharmaceutical interventions. "We found that specific genetic variants in a gene called HMG CoA reductase which normally regulates cholesterol production and mobilization in the brain can interfere with, and delay the onset of Alzheimer's disease by nearly 4 years. This is an exciting breakthrough in a field where successes have been scarce these past few years" says Dr. Poirier, whose previous research led to the discovery that a genetic variant was formally associated with the common form of Alzheimer's disease. "These latest genetic results from Dr. Poirier's team are an important step forward in the understanding of Alzheimer's disease neurobiology, and also the use of genetics to identify an interesting new molecular target that is amenable to therapeutic development" added Brigitte Kieffer, Scientific Director of the Research Centre of the Douglas Mental Health University Institute." A different approach Over the past two decades, research efforts around the globe have focused on identifying genetic and environmental factors responsible for causing or accelerating the progression of the common form of Alzheimer's disease. However, little was known about possible protective genetic factors that can delay or even prevent the disease onset in humans. It is well documented that a subset of older individuals who happen to be carriers of predisposing genetic factors for the common form of Alzheimer's manage to escape the disease and live long and productive lives without any memory problems until their 90's. INFORMATION: About Judes Poirier, PhD, C.Q. Dr. Poirier is internationally renowned for his work on cholesterol and apolipoprotein E in the normal, injured and diseased brain, and was a pioneer in establishing the field of pharmacogenomics of Alzheimer's disease therapies. Author of over 186 research articles and book chapters, Dr. Poirier's numerous honors include: the International Society for Neurochemistry Award; the International Parke-Davis - ICAD Award for his work on apolipoprotein E4, cholesterol and Alzheimer's disease; the 1997 Galien Prize, the CCNP Innovation Award, the Genesis Award; and the Hubert Reeves Award. Personality of the Week by La Presse/Radio-Canada and Personality of the Year by the magazine L'Actualité in 1996. Dr. Poirier received his Ph.D. from the Université de Montréal: he was honored as "Knight of the Order of Quebec" by the Premier of the province of Québec and received an "Honoris Causa" medical doctorate from the Université de Montpellier in 2009 for his pioneering work in the field of Alzheimer's disease. For information and interviews: Florence Meney
Media Relations
Communications and Public Affairs Directorate
Douglas Mental Health University Institute
Dobell Pav.- 6875 LaSalle Blvd., B-2122 - Montreal, QC H4H 1R3
T. 514-761-6131, ext. 2769
Florence.meney@douglas.mcgill.ca About the Douglas Institute
The Douglas is a world-class institute affiliated with McGill University and the World Health Organization. It treats people suffering from mental illness and offers them both hope and healing. Its teams of specialists and researchers are constantly increasing scientific knowledge, integrating this knowledge into patient care, and sharing it with the community in order to educate the public and eliminate prejudices surrounding mental health.

ELSE PRESS RELEASES FROM THIS DATE:

Smallest Swiss cross -- Made of 20 single atoms

2014-07-15

The manipulation of atoms has reached a new level: Together with teams from Finland and Japan, physicists from the University of Basel were able to place 20 single atoms on a fully insulated surface at room temperature to form the smallest "Swiss cross", thus taking a big step towards next generation atomic-scale storage devices. The academic journal Nature Communications has published their results. Ever since the 1990s, physicists have been able to directly control surface structures by moving and positioning single atoms to certain atomic sites. A number of atomic ...

Cholesterol activates signaling pathway that promotes cancer

2014-07-15

Everyone knows that cholesterol, at least the bad kind, can cause heart disease and hardening of the arteries. Now, researchers at the University of Illinois at Chicago describe a new role for cholesterol in the activation of a cellular signaling pathway that has been linked to cancer. The finding is reported in Nature Communications. Cells employ thousands of signaling pathways to conduct their functions. Canonical Wnt signaling is a pathway that promotes cell growth and division and is most active in embryonic cells during development. Overactivity of this signaling ...

Researchers assess emergency radiology response after Boston Marathon bombings

2014-07-15

OAK BROOK, Ill. – An after-action review of the Brigham and Women's Hospital emergency radiology response to the Boston Marathon bombings highlights the crucial role medical imaging plays in emergency situations and ways in which radiology departments can improve their preparedness for mass casualty events. The new study is published online in the journal Radiology. "It's important to analyze our response to events like the Boston Marathon bombing to identify opportunities for improvement in our institutional emergency operations plan," said senior author Aaron Sodickson ...

No anti-clotting treatment needed for most kids undergoing spine surgeries

2014-07-15

Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according to a new Johns Hopkins Children's Center study. Because clotting risk in children is poorly understood, treatment guidelines are largely absent, leaving doctors caring for pediatric patients at a loss on whom to treat and when. The Johns Hopkins' team findings, published online July 15 in the journal Spine, narrow down the pool of high-risk patients ...

Little too late: Researchers identify disease that may have plagued 700-year-old skeleton

2014-07-15

European researchers have recovered a genome of the bacterium Brucella melitensis from a 700-year-old skeleton found in the ruins of a Medieval Italian village. Reporting this week in mBio®, the online open-access journal of the American Society for Microbiology, the authors describe using a technique called shotgun metagenomics to sequence DNA from a calcified nodule in the pelvic region of a middle-aged male skeleton excavated from the settlement of Geridu in Sardinia, an island off the coast of Italy. Geridu is thought to have been abandoned in the late 14th century. ...

Study reveals how gardens could help dementia care

2014-07-15

A new study has revealed that gardens in care homes could provide promising therapeutic benefits for patients suffering from dementia. The research is published in the Journal of the American Medical Directors Association and by critically reviewing the findings from 17 different pieces of research, has found that outdoor spaces can offer environments that promote relaxation, encourage activity and reduce residents' agitation. Conducted by a team at the University of Exeter Medical School and supported by the National Institute for Health Research Collaboration for ...

Fungicides for crops: Worrying link to fungal drug resistance in UK warns scientists

2014-07-15

Crop spraying on British farms could be aiding a life-threatening fungus suffered by tens of thousand of people in the UK each year. New research by British and Dutch scientists has found that Aspergillus – a common fungus that attacks the lungs and is found in soil and other organic matter – has become resistant to life - saving drugs in parts of rural Yorkshire. It's the first time a link has been made in the UK between drug resistance in Aspergillus and fungicide used on crops. Experts warn their findings, now published, are significant and raise serious implications ...

Pre-diabetes label 'unhelpful and unnecessary'

2014-07-15

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota. The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes by a few years, and found no evidence of long-term health benefits. Type 2 diabetes is typically diagnosed ...

Reduced range of facial expression indicates serious heart/lung disease

2014-07-15

Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal. This finding could be used to help busy emergency care doctors decide whom to prioritise for treatment, and gauge who really needs often costly and invasive tests, suggest the researchers. And it adds scientific credibility to the rapid visual assessment doctors make of how sick someone is, formally known as gestalt pretest ...

Patients with advanced co-existing illnesses and their carers face uphill struggle

2014-07-15

Patients in their last year of life with co-existing illnesses struggle to cope with a bewildering array of services and treatments, which are often poorly coordinated and lack any continuity of care, indicates an analysis of patient and carer feedback, published online in BMJ Supportive & Palliative Care. Patients and carers frequently found accessing the support they needed "impersonal" and "challenging," the comments showed. It's important to get this right, say the researchers, because 'multimorbidity,' in which patients are coping with several illnesses at the ...

nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip

While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains

Revolutionizing surface science: Visualization of local dielectric properties of surfaces

[Press-News.org] New hope for treatment of Alzheimer's disease
A genetic variant conveys significant protection

New hope for treatment of Alzheimer's disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: